Skip to content

Can latanoprost cause coughing?: Understanding this rare side effect

5 min read

While not a common side effect, some individuals report experiencing a persistent cough after beginning latanoprost eye drops for glaucoma or ocular hypertension. This reaction is thought to be caused by the systemic absorption of the medication, which can affect receptors in the respiratory tract.

Quick Summary

Latanoprost eye drops can potentially cause coughing, a rare side effect believed to stem from systemic absorption of the drug via the tear ducts. This absorption may heighten cough sensitivity by affecting respiratory tract receptors. User experiences confirm the possibility, often linking it to post-nasal drip, while proper administration techniques can help mitigate risk.

Key Points

  • Rare Occurrence: Coughing is not a common side effect of latanoprost, but it has been reported by a small number of users.

  • Systemic Absorption: The cough is likely caused by the systemic absorption of the medication, which can happen when the eye drop solution drains through the tear ducts into the nasal cavity.

  • Heightened Sensitivity: Latanoprost, as a prostaglandin analogue, can increase cough sensitivity in the respiratory tract due to its effect on prostanoid FP receptors.

  • Manageable with Technique: Using proper eye drop administration, including punctal occlusion (pressing on the inner corner of the eye), can reduce systemic absorption and may alleviate the cough.

  • Consult a Professional: It is crucial to consult your doctor if you experience a persistent cough, as they can confirm the cause and discuss alternative treatment options.

  • Lower Respiratory Risk than Beta-Blockers: Latanoprost carries a lower risk of serious respiratory side effects compared to older glaucoma medications like timolol, especially for those with conditions like asthma.

In This Article

Latanoprost is a prostaglandin F2α analogue, a type of medication widely used to treat elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humor from the eye, effectively lowering the pressure inside. For many, it is a highly effective and well-tolerated treatment, often preferred over other classes of eye drops due to fewer systemic side effects. However, as with any medication, it comes with a range of possible side effects. While most are localized to the eye, such as changes in iris color, eyelash growth, and eye irritation, some individuals report systemic effects, including respiratory issues like coughing.

The Connection Between Latanoprost and Coughing

For most people, latanoprost eye drops do not cause respiratory issues. However, the systemic absorption of the active ingredient has been linked to coughing in some patients. The pharmacological basis for this effect is tied to the way the drug is processed by the body. Latanoprost is a synthetic version of prostaglandin F2α, a substance that naturally occurs in the body and has widespread effects, including on the respiratory system. Specifically, these prostaglandins can interact with FP subtype receptors, which are also found in the respiratory tract. In a rare case reported in the medical literature, a patient's chronic cough coincided with starting latanoprost and disappeared when the medication was stopped. This observation provides compelling evidence that systemic exposure to the drug can increase a person's cough sensitivity.

The Mechanism of Systemic Absorption

When eye drops are administered, not all of the medication remains in the eye. A portion of the liquid can drain from the tear ducts into the nasal cavity and be absorbed into the bloodstream. From there, the active compound, latanoprost acid, can circulate systemically and potentially affect non-ocular tissues. This systemic exposure is believed to be the primary cause of respiratory side effects. User reports from platforms like Drugs.com often describe a cough linked to post-nasal drip, a sensation that the medication is leaking into the throat. This further supports the hypothesis that the issue arises from the drug's journey out of the eye and into the body's general circulation. Simple techniques, such as punctal occlusion, can help minimize this systemic absorption by blocking the tear ducts.

Is Latanoprost-Induced Cough a Common Side Effect?

No, coughing is not a frequent side effect of latanoprost. In clinical trials, respiratory events like upper respiratory tract infection were reported in a small percentage of patients, but a direct link to coughing was not widely documented. Medical databases often list cough under rare or less common side effects, with the incidence rate not well established. User-reported data, while not clinically verified, provides qualitative evidence that for a small number of individuals, a persistent cough is a bothersome symptom. The severity and persistence of the cough can vary significantly among those affected. It is crucial to distinguish this drug-induced cough from other causes, like allergic reactions or pre-existing respiratory conditions.

What to Do If You Experience a Cough on Latanoprost

If you develop a cough after starting latanoprost, it is important to first rule out other potential causes. If the cough persists and is bothersome, several strategies can be considered in consultation with a healthcare provider.

  • Improve Eye Drop Technique: Using proper administration techniques, such as applying pressure to the inner corner of the eye (punctal occlusion) for at least one minute after instilling the drop, can significantly reduce systemic absorption.
  • Discuss with Your Doctor: Never stop your glaucoma medication abruptly without consulting your eye doctor. Discuss your symptoms and concerns. They can help determine if the latanoprost is the cause and recommend a course of action.
  • Consider Alternative Medications: If the cough is clearly linked to latanoprost and cannot be managed, your doctor may switch you to an alternative glaucoma medication. Other prostaglandin analogs or drugs from different classes, like alpha-agonists or rho kinase inhibitors, may be considered.

Comparison of Respiratory Side Effects: Latanoprost vs. Other Glaucoma Drops

Different classes of glaucoma medication have distinct side effect profiles, particularly concerning respiratory issues. For comparison, let's examine latanoprost against the widely used beta-blocker timolol.

Feature Latanoprost (Prostaglandin Analog) Timolol (Beta-Blocker)
Mechanism of Action Increases uveoscleral outflow of aqueous humor. Reduces aqueous humor formation.
Potential for Cough Rare side effect, linked to increased cough sensitivity from systemic absorption. Higher risk of respiratory issues, especially in patients with asthma or COPD, due to systemic beta-blockade.
Specific Respiratory Risks May exacerbate asthma in rare cases. May cause mild respiratory symptoms like sore throat or runny nose. Contraindicated or used with extreme caution in patients with asthma, COPD, or other lung diseases due to risk of bronchospasm.
Systemic Side Effects Low potential for systemic effects; rare reports of chest pain, dizziness, or headache. Higher risk of systemic effects, including slow heartbeat, fatigue, and depression.

Conclusion

In conclusion, can latanoprost cause coughing? Yes, though it is considered a rare side effect. The cough is likely caused by the systemic absorption of the drug, which can heighten cough sensitivity in certain individuals. While the risk is low, particularly compared to older glaucoma medications like beta-blockers, it is a valid concern for some patients. Proper administration techniques, like punctal occlusion, can help minimize systemic exposure and reduce the risk of this side effect. Any persistent cough should be discussed with a healthcare provider to determine the cause and explore alternative treatment options if necessary. Patients should not discontinue their medication without professional medical advice. Always consult your ophthalmologist or pharmacist for guidance on managing side effects and ensuring your treatment remains effective and safe. You can find more information about the potential systemic effects of latanoprost in the official prescribing information from sources like Drugs.com.

How to properly administer eye drops to minimize systemic absorption:

  1. Wash your hands thoroughly before handling the eye drop bottle.
  2. Tilt your head back and gently pull down your lower eyelid to form a small pocket.
  3. Instill one drop into the pocket of your lower eyelid without touching the dropper tip to your eye or lashes.
  4. Immediately close your eyes and press your finger lightly against the inner corner of your eye, near the nose. Maintain this pressure for at least one minute.
  5. Blot any excess solution from your eyelid with a clean tissue.

Frequently Asked Questions

An eye drop can cause a cough if the medication is absorbed systemically. When eye drops are applied, some of the liquid drains through the tear ducts into the nasal cavity and is absorbed into the bloodstream. Latanoprost is a prostaglandin analogue that, when absorbed systemically, can affect receptors in the respiratory tract, leading to increased cough sensitivity in susceptible individuals.

Coughing is a relatively rare side effect of latanoprost. While some user reports and case studies link the medication to heightened cough sensitivity, it is not a common occurrence. Official medical sources often list it with 'incidence not known' or as a less common symptom.

To prevent or reduce systemic absorption, try using punctal occlusion. After putting in your eye drops, close your eyes and gently press a finger against the inner corner of your eye, next to your nose, for at least one minute. This technique helps prevent the solution from draining into your tear duct.

No, the cough is generally not permanent. If the cough is indeed caused by latanoprost, it should resolve after discontinuing the medication, as shown in case reports. However, you should never stop your medication without first speaking to your doctor.

In rare cases, latanoprost has been reported to exacerbate asthma. Patients with pre-existing respiratory conditions like asthma or COPD should use caution and discuss all risks with their doctor. Older glaucoma medications like beta-blockers carry a higher risk of serious respiratory issues.

If you experience a severe or persistent cough, especially if accompanied by difficulty breathing, wheezing, or chest pain, seek immediate medical attention. These could be signs of a serious allergic reaction or other medical condition.

Your doctor may recommend switching to an alternative if the cough is bothersome and clearly linked to latanoprost. However, any decision to change medication should be made in consultation with your healthcare provider, who can weigh the risks and benefits of other options.

The brand of latanoprost (e.g., Xalatan) versus a generic version should not significantly impact the risk of a drug-induced cough, as the active ingredient is the same. The preservative used, such as benzalkonium chloride, can cause local irritation, but the systemic effect is linked to latanoprost itself.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.